Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Descrição
This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.
CPHI: ESG Risks in Pharma and Biotech – How to Manage your Exposure (webinar)
Translational biomarkers in the era of precision medicine - ScienceDirect
Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests
Biologics, Free Full-Text
Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic
Molecules imagined using advanced artificial intelligence show promising results in pre-clinical experiments
IJMS, Free Full-Text
Metabolomics: small molecules that matter more - Molecular Omics (RSC Publishing) DOI:10.1039/D0MO00176G
The expanding role for small molecules in immuno-oncology
AI Drug Discovery: Key Trends and Developments in Pharma Industry
Cancers, Free Full-Text
Bridging the preclinical to clinical divide: practical considerations for biomarker success
Biomarker development in the precision medicine era: lung cancer as a case study
A precision medicine–based, 'fast-fail' approach for psychiatry
Fierce Pharma Feature: Small molecule biomarkers in precision medicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
